美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

阿斯利康

161.85

-1.9300-1.18%

盤後：163.721.87+1.16%16:36 EDT

成交量：292.46萬

成交額：4.75億

市值：2,510.29億

市盈率：24.23

高：163.90

開：161.42

低：160.71

收：163.78

52周最高：212.71

52周最低：145.79

股本：15.51億

流通股本：14.99億

量比：0.85

換手率：0.20%

股息：3.16

股息率：1.95%

每股收益(TTM):6.68

每股收益(LYR):6.54

淨資產收益率：21.96%

總資產收益率：8.02%

市淨率：4.99

市盈率(LYR):24.75

資料載入中...

總覽公司新聞資訊公告

DESTINY-Lung04 III期臨床研究顯示，優赫得®一線治療HER2突變晚期非小細胞肺癌患者的中位無進展生存期達14.3個月

異動解讀｜阿斯利康盤後下跌3.65%，報154.61美元

阿斯利康的乳腺癌藥物晚期臨床試驗失敗

投洽會「金鑰匙」再啓：雙向投資動能強勁，未來產業站上C位

安進（AMGN）聯合療法III期臨床達主要終點

Tozorakimab在OBERON和TITANIA兩項Ⅲ期臨床試驗中，在降低慢阻肺病急性加重方面均顯示出統計學和臨床意義上的顯著改善

商務部新增84個全國重點外資項目

美國食品藥品監督管理局（FDA）加速批准阿斯利康(AZN.O)的Etcamah，用於治療伴有ESR1突變的晚期乳腺癌。

阿斯利康（AZN）抗體偶聯藥物Enhertu聯合療法獲歐盟新適應症批准

異動解讀｜阿斯利康夜盤下跌4.14%，多重管線挫折與競爭壓力持續承壓

療效碾壓阿斯利康(AZN.US)Imfinzi！Summit(SMMT.US)依沃西單抗III期試驗數據積極，股價應聲大漲

國藥控股與阿斯利康啓動基藥惠民專項合作

迪哲醫藥上半年營收破5億，已與阿斯利康達成舒沃替尼全球獨家許可協議

阿斯利康長效C5補體抑制劑偉立瑞獲批上市

南方财经网

偉立瑞®在華獲批用於治療成人和1月齡及以上兒童陣發性睡眠性血紅蛋白尿症（PNH）患者

阿斯利康(AZN.US)瑞利珠單抗第3項適應症在中國獲批上市

異動解讀｜阿斯利康盤中上漲3.1%，多項肺癌III期研究積極結果疊加製藥板塊集體走強

阿斯利康(AZN.US)單抗新藥兩項適應症在中國上市

第3次更新-阿斯利康因暫停volrustomig肺癌臨床試驗再遭挫折

阿斯利康(AZN.US)/第一三共ADC一線治療肺癌III期研究成功

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/AZN/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AZN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZN\",,,,,undefined,":{"symbol":"AZN","market":"US","secType":"STK","nameCN":"阿斯利康","latestPrice":161.85,"timestamp":1789502400000,"preClose":163.78,"halted":0,"volume":2924603,"hourTrading":{"tag":"盘后","latestPrice":163.72,"preClose":161.85,"latestTime":"16:36 EDT","volume":1916,"amount":310653.6298,"timestamp":1789504600958,"change":1.87,"changeRate":0.011554,"amplitude":0.013167},"delay":0,"changeRate":-0.011784100622786706,"floatShares":1498932637,"shares":1551000000,"eps":6.679974,"marketStatus":"盤後交易","change":-1.93,"latestTime":"09-15 16:38:05 EDT","open":161.42,"high":163.9,"low":160.71,"amount":474987317.63460994,"amplitude":0.019477,"askPrice":163.72,"askSize":10,"bidPrice":160,"bidSize":250,"shortable":3,"etf":0,"ttmEps":6.679974,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":4,"adr":1,"adrRate":0.5,"listingDate":737179200000,"exchange":"NYSE","adjPreClose":163.78,"dividendRate":0.01953,"preHourTrading":{"tag":"盘前","latestPrice":161.43,"preClose":163.78,"latestTime":"09:29 EDT","volume":36635,"amount":5945424.177150001,"timestamp":1789478999999,"change":-2.35,"changeRate":-0.014349,"amplitude":0.014349},"postHourTrading":{"tag":"盘后","latestPrice":163.72,"preClose":161.85,"latestTime":"16:36 EDT","volume":1916,"amount":310653.6298,"timestamp":1789504600958,"change":1.87,"changeRate":0.011554,"amplitude":0.013167},"volumeRatio":0.846299,"impliedVol":0.2921,"impliedVolPercentile":0.5538},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZN\",,,,,undefined,":{"symbol":"AZN","floatShares":1498932637,"roa":"8.02%","roe":"21.96%","lyrEps":6.54,"volumeRatio":0.846299,"shares":1551000000,"dividePrice":3.161,"high":163.9,"amplitude":0.019477,"preClose":163.78,"low":160.71,"week52Low":145.79,"pbRate":"4.99","psRate":"4.09","week52High":212.71,"institutionHeld":0,"latestPrice":161.85,"committee":0.923077,"eps":6.679974,"divideRate":0.01953,"volume":2924603,"delay":0,"ttmEps":6.679974,"open":161.42,"prevYearClose":183.86,"prevWeekClose":160.17,"prevMonthClose":162.13,"prevQuarterClose":189.62,"fiveDayClose":160.04,"twentyDayClose":156.89,"sixtyDayClose":174.93,"dividendPayoutRate":0.4744743415493694,"dividendFrequency":"S","dividendGrowthYears":1,"dividendGrowthRate":2.13,"fiveYearAvgDividendRate":0.01800023813182617},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZN\",params:#limit:5,,,undefined,":[{"date":"2026-10-30","symbol":"AZN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1793347200000,"name":null,"time":"盤前","dateTimestamp":1793332800000,"actualEps":null},{"date":"2026-08-07","symbol":"AZN","amount":1.06,"announcedDate":"2026-07-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-07","defaultRemindTime":1786109400000,"name":"阿斯利康","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-08","payableDate":"2026-08-07","currency":"USD","dateTimestamp":1786075200000,"payDate":"2026-09-08"},{"market":"US","date":"2026-07-27","symbol":"AZN","fiscalQuarterEnding":"2026/06","expectedEps":2.5,"name":null,"time":"盤前","type":"earning","dateTimestamp":1785124800000,"reportTimeType":"pre","actualEps":2.63},{"market":"US","date":"2026-04-29","symbol":"AZN","fiscalQuarterEnding":"2026/03","expectedEps":2.57,"name":null,"time":"盤前","type":"earning","dateTimestamp":1777435200000,"reportTimeType":"pre","actualEps":2.58},{"date":"2026-02-20","symbol":"AZN","amount":2.17,"announcedDate":"2026-02-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-20","defaultRemindTime":1771597800000,"name":"阿斯利康","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-02-20","currency":"USD","dateTimestamp":1771563600000,"payDate":"2026-03-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZN\",market:\"US\",,,undefined,":[{"executeDate":"2017-02-15","recordDate":"2017-02-17","paymentDate":"2017-03-20","value":0.93,"currency":"USD"},{"executeDate":"2017-08-09","recordDate":"2017-08-11","paymentDate":"2017-09-11","value":0.44,"currency":"USD"},{"executeDate":"2018-02-15","recordDate":"2018-02-16","paymentDate":"2018-03-19","value":0.93,"currency":"USD"},{"executeDate":"2018-08-09","recordDate":"2018-08-10","paymentDate":"2018-09-10","value":0.44,"currency":"USD"},{"executeDate":"2019-02-28","recordDate":"2019-03-01","paymentDate":"2019-03-27","value":0.93,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3846,"buy":0.5385,"hold":0.0769,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5385,"analysts":13,"updateTime":1787630400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AZN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AZN","date":"2026-09-14","current":24.51806,"percent":0.128395,"low":-196.839437,"twenty":27.847688,"median":33.179817,"eighty":50.604003,"high":1968.240717,"avg":97.271125,"sd":365.986317,"marketCap":254113432295.37},"quantilePoints":[{"date":"2021-09-17","current":45.556592,"twenty":33.811774,"median":41.895286,"eighty":61.949531,"marketCap":171793907663.64},{"date":"2021-09-24","current":49.669587,"twenty":33.811774,"median":41.895286,"eighty":61.607974,"marketCap":187304013407.33},{"date":"2021-10-01","current":48.824353,"twenty":33.811774,"median":41.895286,"eighty":61.248398,"marketCap":184116632093.75},{"date":"2021-10-08","current":49.800513,"twenty":33.811774,"median":41.895286,"eighty":61.020009,"marketCap":187797735584.04},{"date":"2021-10-15","current":49.71937,"twenty":33.811774,"median":41.895286,"eighty":60.739134,"marketCap":187491745853.75},{"date":"2021-10-22","current":50.871053,"twenty":33.811774,"median":41.895286,"eighty":60.537147,"marketCap":191834739729.65},{"date":"2021-10-29","current":51.128224,"twenty":33.81353,"median":41.897331,"eighty":60.445661,"marketCap":192804535774.89},{"date":"2021-11-05","current":51.586876,"twenty":33.81353,"median":41.897331,"eighty":60.445661,"marketCap":194534108269.15},{"date":"2021-11-12","current":124.32333,"twenty":33.81353,"median":41.917192,"eighty":60.445661,"marketCap":182879619363.67},{"date":"2021-11-19","current":120.23438,"twenty":33.81353,"median":42.14268,"eighty":60.685883,"marketCap":176864773031.09},{"date":"2021-11-26","current":117.962901,"twenty":33.81353,"median":42.190627,"eighty":60.88723,"marketCap":173523426730.59},{"date":"2021-12-03","current":114.058101,"twenty":33.81353,"median":42.459679,"eighty":61.11746,"marketCap":167779466800.21},{"date":"2021-12-10","current":114.181064,"twenty":33.81353,"median":42.699465,"eighty":61.452265,"marketCap":167960345018.33},{"date":"2021-12-17","current":118.980811,"twenty":33.81353,"median":42.837881,"eighty":61.891111,"marketCap":175020772922.72},{"date":"2021-12-23","current":121.330793,"twenty":33.81353,"median":42.933402,"eighty":62.081355,"marketCap":178477596827.59},{"date":"2021-12-31","current":123.748715,"twenty":33.81353,"median":43.007672,"eighty":62.499235,"marketCap":182034359116.88},{"date":"2022-01-07","current":120.050561,"twenty":33.815286,"median":43.097412,"eighty":62.953761,"marketCap":176594376318.68},{"date":"2022-01-14","current":123.058267,"twenty":33.815286,"median":43.234717,"eighty":63.424083,"marketCap":181018710009.44},{"date":"2022-01-21","current":124.994373,"twenty":33.815286,"median":43.372927,"eighty":63.548212,"marketCap":183866722078.34},{"date":"2022-01-28","current":123.976416,"twenty":33.815286,"median":43.552363,"eighty":63.706505,"marketCap":182369309247.62},{"date":"2022-02-04","current":118.184057,"twenty":33.815286,"median":43.622491,"eighty":63.860585,"marketCap":173848748288.24},{"date":"2022-02-11","current":1601.026247,"twenty":33.817042,"median":43.82776,"eighty":64.00879,"marketCap":179314939563.19},{"date":"2022-02-18","current":1654.401018,"twenty":33.817042,"median":43.939798,"eighty":64.169686,"marketCap":185292914010.65},{"date":"2022-02-25","current":1668.738174,"twenty":33.817042,"median":44.078325,"eighty":64.295473,"marketCap":186898675368.11},{"date":"2022-03-04","current":1586.663703,"twenty":33.817042,"median":44.224518,"eighty":64.600266,"marketCap":177706334684.76},{"date":"2022-03-11","current":1675.474001,"twenty":33.817042,"median":44.467018,"eighty":65.166625,"marketCap":187653088130.53},{"date":"2022-03-18","current":1738.306661,"twenty":33.817042,"median":44.572948,"eighty":65.784088,"marketCap":194690345992.99},{"date":"2022-03-25","current":1795.841809,"twenty":33.817042,"median":44.572948,"eighty":66.489581,"marketCap":201134282573.26},{"date":"2022-04-01","current":1827.083488,"twenty":33.817042,"median":44.572948,"eighty":66.698379,"marketCap":204633350610.8},{"date":"2022-04-08","current":1968.240717,"twenty":33.817042,"median":44.599854,"eighty":66.956295,"marketCap":220442960330.62},{"date":"2022-04-14","current":1903.633793,"twenty":33.817042,"median":44.664609,"eighty":67.127776,"marketCap":213206984758.84},{"date":"2022-04-22","current":1827.31022,"twenty":33.817042,"median":45.008047,"eighty":67.494417,"marketCap":204658744606.77},{"date":"2022-04-29","current":-195.561143,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":207881494412.78},{"date":"2022-05-06","current":-186.047843,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":197768857946.09},{"date":"2022-05-13","current":-183.445869,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":195002958947.03},{"date":"2022-05-20","current":-190.668769,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":202680901868.49},{"date":"2022-05-27","current":-194.54477,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":206801090657.37},{"date":"2022-06-03","current":-190.374978,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":202368602400.22},{"date":"2022-06-10","current":-176.891963,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":188036156437.33},{"date":"2022-06-17","current":-176.59081,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":187716030487.33},{"date":"2022-06-24","current":-193.054847,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":205217301659.23},{"date":"2022-07-01","current":-188.578174,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":200458598457.74},{"date":"2022-07-08","current":-193.728763,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":205933674494.87},{"date":"2022-07-15","current":-192.228519,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":204338915909.36},{"date":"2022-07-22","current":-188.718222,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":200607469952.86},{"date":"2022-07-29","current":-163.162978,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":204443212506.84},{"date":"2022-08-05","current":-161.84855,"twenty":33.804057,"median":45.556592,"eighty":67.618433,"marketCap":202796233583.46},{"date":"2022-08-12","current":-160.589567,"twenty":33.804057,"median":45.556592,"eighty":67.618433,"marketCap":201218726783.29},{"date":"2022-08-19","current":-164.33585,"twenty":33.804057,"median":45.556592,"eighty":67.618433,"marketCap":205912819247.31},{"date":"2022-08-26","current":-165.535736,"twenty":33.804057,"median":45.556592,"eighty":67.618433,"marketCap":207416276963.04},{"date":"2022-09-02","current":-151.980645,"twenty":33.793274,"median":45.556592,"eighty":67.618433,"marketCap":190431747964.03},{"date":"2022-09-09","current":-150.350821,"twenty":33.759854,"median":45.556592,"eighty":67.618433,"marketCap":188389579323.08},{"date":"2022-09-16","current":-142.971469,"twenty":33.462713,"median":45.556592,"eighty":67.618433,"marketCap":179143250929.75},{"date":"2022-09-23","current":-135.412757,"twenty":33.234819,"median":45.556592,"eighty":67.618433,"marketCap":169672185276.98},{"date":"2022-09-30","current":-137.024975,"twenty":33.070312,"median":45.556592,"eighty":67.618433,"marketCap":171692293015.61},{"date":"2022-10-07","current":-137.934582,"twenty":32.990313,"median":45.556592,"eighty":67.618433,"marketCap":172832030829.71},{"date":"2022-10-14","current":-136.189836,"twenty":32.851802,"median":45.556592,"eighty":67.618433,"marketCap":170645864409.42},{"date":"2022-10-21","current":-134.729179,"twenty":32.794598,"median":45.556592,"eighty":67.618433,"marketCap":168815662212.36},{"date":"2022-10-28","current":-145.085703,"twenty":32.578746,"median":45.556592,"eighty":67.618433,"marketCap":181792385725.21},{"date":"2022-11-04","current":-150.046253,"twenty":32.441126,"median":45.556592,"eighty":67.618433,"marketCap":188007955286.73},{"date":"2022-11-11","current":94.735808,"twenty":32.406054,"median":46.033505,"eighty":67.825263,"marketCap":193261049543.38},{"date":"2022-11-18","current":98.881438,"twenty":32.406054,"median":46.253226,"eighty":68.270745,"marketCap":201718134504.01},{"date":"2022-11-25","current":100.570487,"twenty":32.406054,"median":46.494,"eighty":68.630373,"marketCap":205163794032.47},{"date":"2022-12-02","current":104.001851,"twenty":32.406054,"median":46.662739,"eighty":69.183829,"marketCap":212163775968.3},{"date":"2022-12-09","current":106.087706,"twenty":32.406054,"median":47.149871,"eighty":69.716808,"marketCap":216418920541.74},{"date":"2022-12-16","current":102.978508,"twenty":32.406054,"median":47.231592,"eighty":77.51575,"marketCap":210076156888.69},{"date":"2022-12-23","current":102.942288,"twenty":32.406054,"median":47.744626,"eighty":80.277721,"marketCap":210002267642.7},{"date":"2022-12-30","current":102.667462,"twenty":32.406054,"median":47.889649,"eighty":84.998822,"marketCap":209441622638.71},{"date":"2023-01-06","current":107.816944,"twenty":32.458836,"median":48.074276,"eighty":86.203785,"marketCap":219946565887.33},{"date":"2023-01-13","current":108.069807,"twenty":32.750787,"median":48.137803,"eighty":87.690545,"marketCap":220462406785.54},{"date":"2023-01-20","current":105.346185,"twenty":32.842448,"median":48.225012,"eighty":88.132026,"marketCap":214906218177.77},{"date":"2023-01-27","current":99.91328,"twenty":32.990313,"median":48.365293,"eighty":89.493625,"marketCap":203823092868.29},{"date":"2023-02-03","current":97.194847,"twenty":33.091636,"median":48.590919,"eighty":89.958492,"marketCap":198277488061.49},{"date":"2023-02-10","current":64.79374,"twenty":34.704276,"median":48.67565,"eighty":90.227834,"marketCap":213041815934.3},{"date":"2023-02-17","current":64.947931,"twenty":34.925603,"median":48.824353,"eighty":90.227834,"marketCap":213548799709.69},{"date":"2023-02-24","current":62.505092,"twenty":34.952202,"median":48.879329,"eighty":90.227834,"marketCap":205516742935.99},{"date":"2023-03-03","current":60.884824,"twenty":35.166348,"median":49.034331,"eighty":90.227834,"marketCap":200189300543.79},{"date":"2023-03-10","current":60.817416,"twenty":35.244416,"median":49.259346,"eighty":90.227834,"marketCap":199967660996.94},{"date":"2023-03-17","current":62.038789,"twenty":35.50748,"median":49.397527,"eighty":90.227834,"marketCap":203983536730.65},{"date":"2023-03-24","current":63.847982,"twenty":35.636896,"median":49.622888,"eighty":90.227834,"marketCap":209932167388.35},{"date":"2023-03-31","current":65.498173,"twenty":35.705258,"median":49.69358,"eighty":90.221194,"marketCap":215357992309.98},{"date":"2023-04-06","current":68.570831,"twenty":35.757541,"median":49.714558,"eighty":90.221194,"marketCap":225460889410.27},{"date":"2023-04-14","current":70.200873,"twenty":35.964313,"median":49.945228,"eighty":90.227834,"marketCap":230820471067.89},{"date":"2023-04-21","current":71.517248,"twenty":36.054882,"median":50.706874,"eighty":90.227834,"marketCap":235148709402.74},{"date":"2023-04-27","current":48.542146,"twenty":36.18562,"median":50.911319,"eighty":90.227834,"marketCap":228390801103.1},{"date":"2023-05-05","current":49.347014,"twenty":36.268071,"median":50.945363,"eighty":90.234475,"marketCap":232177702207.76},{"date":"2023-05-12","current":49.504739,"twenty":36.37963,"median":50.979408,"eighty":90.241115,"marketCap":232919796188.45},{"date":"2023-05-19","current":49.107772,"twenty":36.442091,"median":51.05333,"eighty":90.273874,"marketCap":231052066290.14},{"date":"2023-05-26","current":47.846336,"twenty":36.591375,"median":51.060903,"eighty":90.299991,"marketCap":225117008406.37},{"date":"2023-06-02","current":48.462782,"twenty":36.80131,"median":51.068476,"eighty":90.326109,"marketCap":228017386013.05},{"date":"2023-06-09","current":48.413705,"twenty":36.956644,"median":51.09835,"eighty":90.352226,"marketCap":227786482533.35},{"date":"2023-06-16","current":49.548607,"twenty":37.011895,"median":51.09835,"eighty":90.352226,"marketCap":233126199438.55},{"date":"2023-06-23","current":47.927025,"twenty":37.145966,"median":51.128224,"eighty":90.378344,"marketCap":225496652662.89},{"date":"2023-06-29","current":46.686861,"twenty":37.277576,"median":51.128224,"eighty":90.378344,"marketCap":219661682991.5},{"date":"2023-07-07","current":42.266477,"twenty":37.450916,"median":51.137896,"eighty":90.382517,"marketCap":198863776215.19},{"date":"2023-07-14","current":44.543915,"twenty":37.668194,"median":51.147569,"eighty":90.38669,"marketCap":209579116648.77},{"date":"2023-07-20","current":45.272526,"twenty":37.899674,"median":51.147569,"eighty":90.38669,"marketCap":213007237009.48},{"date":"2023-07-28","current":46.8505,"twenty":38.043422,"median":51.198971,"eighty":90.390862,"marketCap":220431604774.28},{"date":"2023-08-04","current":34.891689,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":215037480780.58},{"date":"2023-08-11","current":35.26449,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":217335048660.17},{"date":"2023-08-18","current":34.16614,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":210565921407.54},{"date":"2023-08-25","current":33.869471,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":208737548997.49},{"date":"2023-09-01","current":34.101255,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":210166031129.92},{"date":"2023-09-08","current":34.014193,"twenty":38.076047,"median":51.265357,"eighty":90.402485,"marketCap":209629465144.03},{"date":"2023-09-15","current":34.144205,"twenty":38.076047,"median":51.265357,"eighty":90.402485,"marketCap":210430732865.46},{"date":"2023-09-22","current":34.173978,"twenty":38.142274,"median":51.271456,"eighty":90.405762,"marketCap":210614226640.52},{"date":"2023-09-29","current":34.077187,"twenty":38.185365,"median":51.277556,"eighty":90.40904,"marketCap":210017704350},{"date":"2023-10-06","current":33.461697,"twenty":38.185365,"median":51.277556,"eighty":90.40904,"marketCap":206224433900},{"date":"2023-10-13","current":33.700939,"twenty":38.185365,"median":51.277556,"eighty":90.40904,"marketCap":207698886830.05},{"date":"2023-10-20","current":31.854117,"twenty":38.185365,"median":51.277556,"eighty":90.40904,"marketCap":196316921973.67},{"date":"2023-10-27","current":30.825604,"twenty":38.239617,"median":51.294062,"eighty":90.41603,"marketCap":189978199121.01},{"date":"2023-11-03","current":31.446977,"twenty":38.239617,"median":51.294062,"eighty":90.41603,"marketCap":193807722775.81},{"date":"2023-11-10","current":32.576944,"twenty":38.185708,"median":51.294062,"eighty":90.41603,"marketCap":192073660849.91},{"date":"2023-11-17","current":33.492327,"twenty":38.038501,"median":51.294062,"eighty":90.41603,"marketCap":197470761267.37},{"date":"2023-11-24","current":33.532656,"twenty":37.946854,"median":51.294062,"eighty":90.41603,"marketCap":197708536718.25},{"date":"2023-12-01","current":33.915355,"twenty":37.668451,"median":51.294062,"eighty":90.41603,"marketCap":199964933886.19},{"date":"2023-12-08","current":33.457568,"twenty":37.464611,"median":51.286265,"eighty":90.415594,"marketCap":197265816339.95},{"date":"2023-12-15","current":34.186234,"twenty":37.210418,"median":51.286265,"eighty":90.415594,"marketCap":201562040512.73},{"date":"2023-12-22","current":34.744053,"twenty":37.103714,"median":51.286265,"eighty":90.415594,"marketCap":204850936396.91},{"date":"2023-12-29","current":35.502272,"twenty":37.004613,"median":51.294062,"eighty":90.41603,"marketCap":209321397367.75},{"date":"2024-01-05","current":35.915235,"twenty":36.741256,"median":51.301859,"eighty":90.416466,"marketCap":211756222293.47},{"date":"2024-01-12","current":36.28455,"twenty":36.334148,"median":51.301859,"eighty":90.416466,"marketCap":213933708276.37},{"date":"2024-01-19","current":35.054357,"twenty":36.147608,"median":51.316432,"eighty":90.416903,"marketCap":206680482585.36},{"date":"2024-01-26","current":35.21195,"twenty":35.750631,"median":51.301859,"eighty":90.416466,"marketCap":207609659830.59},{"date":"2024-02-02","current":34.611292,"twenty":35.488516,"median":51.301859,"eighty":90.416466,"marketCap":204068178014.97},{"date":"2024-02-09","current":32.042332,"twenty":35.415951,"median":51.301859,"eighty":90.416466,"marketCap":190812082322.82},{"date":"2024-02-16","current":33.046703,"twenty":35.234976,"median":51.301859,"eighty":90.416466,"marketCap":196793117826.02},{"date":"2024-02-23","current":33.625836,"twenty":35.160006,"median":51.301859,"eighty":90.416466,"marketCap":200241851316.37},{"date":"2024-03-01","current":33.150124,"twenty":34.950737,"median":51.294062,"eighty":90.41603,"marketCap":197408989034.17},{"date":"2024-03-08","current":33.961877,"twenty":34.884115,"median":51.294062,"eighty":90.41603,"marketCap":202242978023.88},{"date":"2024-03-15","current":34.178971,"twenty":34.843983,"median":51.294062,"eighty":90.41603,"marketCap":203535777995.74},{"date":"2024-03-22","current":34.569497,"twenty":34.797981,"median":51.294062,"eighty":90.41603,"marketCap":205861353801.33},{"date":"2024-03-28","current":35.138443,"twenty":34.738617,"median":51.294062,"eighty":90.41603,"marketCap":209249428257.93},{"date":"2024-04-05","current":35.017877,"twenty":34.712808,"median":51.301859,"eighty":90.416466,"marketCap":208531458010.87},{"date":"2024-04-12","current":36.040239,"twenty":34.712808,"median":51.301859,"eighty":90.416466,"marketCap":214619626779.03},{"date":"2024-04-19","current":35.516317,"twenty":34.712808,"median":51.301859,"eighty":90.416466,"marketCap":211499662791.19},{"date":"2024-04-26","current":36.676755,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":232200540199.91},{"date":"2024-05-03","current":36.8693,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":233419536058.18},{"date":"2024-05-10","current":37.90429,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":239972059656.37},{"date":"2024-05-17","current":37.573079,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":237875168240.39},{"date":"2024-05-24","current":38.271406,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":242296270130.04},{"date":"2024-05-31","current":38.035274,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":240801317006.26},{"date":"2024-06-07","current":39.311051,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":248878266840.98},{"date":"2024-06-14","current":39.080088,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":247416040543.47},{"date":"2024-06-21","current":38.711485,"twenty":34.712808,"median":51.301859,"eighty":90.416466,"marketCap":245082412423.47},{"date":"2024-06-28","current":38.258325,"twenty":34.703903,"median":51.387168,"eighty":90.437103,"marketCap":242213457601.51},{"date":"2024-07-05","current":37.686159,"twenty":34.703903,"median":51.387168,"eighty":90.437103,"marketCap":238591075664.77},{"date":"2024-07-12","current":38.775783,"twenty":34.703903,"median":51.387168,"eighty":90.437103,"marketCap":245489481019.61},{"date":"2024-07-15","current":38.484698,"twenty":34.703903,"median":51.387168,"eighty":90.437103,"marketCap":243646624421.22},{"date":"2024-08-02","current":38.76335,"twenty":34.59882,"median":51.492254,"eighty":90.59886,"marketCap":249635972195.12},{"date":"2024-08-09","current":38.89894,"twenty":34.59882,"median":51.294062,"eighty":90.59886,"marketCap":250509172617.5},{"date":"2024-08-16","current":40.397147,"twenty":34.59882,"median":51.060903,"eighty":90.59886,"marketCap":260157622811.64},{"date":"2024-08-23","current":41.20613,"twenty":34.59882,"median":50.717669,"eighty":90.59886,"marketCap":265367483505.69},{"date":"2024-08-30","current":42.055252,"twenty":34.59882,"median":50.035509,"eighty":90.59886,"marketCap":270835826209.18},{"date":"2024-09-06","current":40.0627,"twenty":34.59882,"median":49.699751,"eighty":90.59886,"marketCap":258003788372.74},{"date":"2024-09-13","current":37.541027,"twenty":34.59882,"median":49.61335,"eighty":90.59886,"marketCap":241764208376.59},{"date":"2024-09-20","current":37.638672,"twenty":34.59882,"median":49.509177,"eighty":90.59886,"marketCap":242393042178.33},{"date":"2024-09-27","current":37.625615,"twenty":34.59882,"median":49.286663,"eighty":90.59886,"marketCap":242308957210.11},{"date":"2024-10-04","current":37.048339,"twenty":34.59882,"median":49.111103,"eighty":90.59886,"marketCap":238591303207.03},{"date":"2024-10-11","current":36.952592,"twenty":34.59882,"median":48.955607,"eighty":90.59886,"marketCap":237974690511.11},{"date":"2024-10-18","current":37.277326,"twenty":34.59882,"median":48.824043,"eighty":90.59886,"marketCap":240065978538.81},{"date":"2024-10-25","current":36.219041,"twenty":34.59882,"median":48.705135,"eighty":90.59886,"marketCap":233250622910.59},{"date":"2024-10-31","current":34.214563,"twenty":34.574738,"median":48.556466,"eighty":90.59886,"marketCap":220341789337.11},{"date":"2024-11-08","current":30.94958,"twenty":34.409381,"median":48.405215,"eighty":90.61471,"marketCap":199315297141.26},{"date":"2024-11-15","current":30.278774,"twenty":34.310083,"median":48.308272,"eighty":90.61471,"marketCap":196660634447.86},{"date":"2024-11-22","current":31.513145,"twenty":34.186234,"median":48.222861,"eighty":90.61471,"marketCap":204677872404.93},{"date":"2024-11-29","current":32.112113,"twenty":34.16614,"median":48.127581,"eighty":90.61471,"marketCap":208568177906.67},{"date":"2024-12-06","current":32.437834,"twenty":34.130516,"median":47.956432,"eighty":90.61471,"marketCap":210683725873.77},{"date":"2024-12-13","current":31.735912,"twenty":34.077187,"median":47.36104,"eighty":90.61471,"marketCap":206124752986.75},{"date":"2024-12-20","current":30.747177,"twenty":33.965862,"median":47.158831,"eighty":90.61471,"marketCap":199702915335.92},{"date":"2024-12-27","current":31.253559,"twenty":33.915355,"median":46.947642,"eighty":90.61471,"marketCap":202991871173.56},{"date":"2025-01-03","current":31.292576,"twenty":33.861252,"median":46.643867,"eighty":90.61471,"marketCap":203245281002.46},{"date":"2025-01-10","current":32.234446,"twenty":33.727001,"median":46.406597,"eighty":90.65359,"marketCap":209362728493.97},{"date":"2025-01-17","current":31.94661,"twenty":33.648774,"median":45.807185,"eighty":90.65359,"marketCap":207493237604.76},{"date":"2025-01-24","current":32.550101,"twenty":33.596764,"median":45.422812,"eighty":90.65359,"marketCap":211412903531.46},{"date":"2025-01-31","current":33.75602,"twenty":33.533107,"median":44.889475,"eighty":90.65359,"marketCap":219245348015.01},{"date":"2025-02-07","current":31.815023,"twenty":33.517373,"median":44.556858,"eighty":90.65359,"marketCap":223818687137.12},{"date":"2025-02-14","current":32.356027,"twenty":33.43473,"median":43.745721,"eighty":90.65359,"marketCap":227624649448.94},{"date":"2025-02-21","current":32.60623,"twenty":33.370464,"median":43.206289,"eighty":90.41603,"marketCap":229384833994.16},{"date":"2025-02-28","current":33.297502,"twenty":33.297026,"median":42.86189,"eighty":90.196276,"marketCap":234247926833.79},{"date":"2025-03-07","current":34.342579,"twenty":33.296549,"median":42.266477,"eighty":89.763533,"marketCap":241600044097.11},{"date":"2025-03-14","current":34.223161,"twenty":33.289955,"median":41.916906,"eighty":89.650259,"marketCap":240759931866.61},{"date":"2025-03-21","current":33.174158,"twenty":33.275366,"median":41.821537,"eighty":89.650259,"marketCap":233380202105.67},{"date":"2025-03-28","current":32.611493,"twenty":33.192075,"median":41.337415,"eighty":89.650259,"marketCap":229421855281.37},{"date":"2025-04-04","current":31.260761,"twenty":33.125053,"median":41.199067,"eighty":89.650259,"marketCap":219919458662.82},{"date":"2025-04-11","current":28.594151,"twenty":33.037318,"median":41.064599,"eighty":89.636216,"marketCap":201159849729.73},{"date":"2025-04-17","current":29.581448,"twenty":33.006368,"median":40.989973,"eighty":88.809353,"marketCap":208105481337.82},{"date":"2025-04-25","current":30.491371,"twenty":32.783239,"median":40.827536,"eighty":71.444046,"marketCap":214506794307},{"date":"2025-05-02","current":28.51286,"twenty":32.645488,"median":40.694901,"eighty":70.207612,"marketCap":221601942295.02},{"date":"2025-05-09","current":27.170306,"twenty":32.566207,"median":40.439632,"eighty":69.395159,"marketCap":211167616410.88},{"date":"2025-05-16","current":27.370887,"twenty":32.435824,"median":40.15966,"eighty":69.006146,"marketCap":212726533009.73},{"date":"2025-05-23","current":27.957316,"twenty":32.322678,"median":39.976605,"eighty":68.630373,"marketCap":217284264528.17},{"date":"2025-05-30","current":28.851396,"twenty":32.241293,"median":39.748319,"eighty":68.346102,"marketCap":224233046530.51},{"date":"2025-06-06","current":29.243478,"twenty":32.08057,"median":39.714328,"eighty":68.12701,"marketCap":227280309755.04},{"date":"2025-06-13","current":29.77937,"twenty":32.02311,"median":39.480288,"eighty":67.717165,"marketCap":231445260111.41},{"date":"2025-06-20","current":27.833441,"twenty":31.960861,"median":39.343784,"eighty":67.509122,"marketCap":216321500558.44},{"date":"2025-06-27","current":28.009906,"twenty":31.854159,"median":39.123141,"eighty":67.186585,"marketCap":217692984791.35},{"date":"2025-07-03","current":27.802257,"twenty":31.80714,"median":39.024693,"eighty":66.962775,"marketCap":216079143172.01},{"date":"2025-07-11","current":28.279428,"twenty":31.714807,"median":38.870711,"eighty":66.731474,"marketCap":219787712681.75},{"date":"2025-07-18","current":27.545673,"twenty":31.491876,"median":38.769566,"eighty":66.520788,"marketCap":214084974334.11},{"date":"2025-07-25","current":29.172645,"twenty":31.404097,"median":38.671164,"eighty":66.049074,"marketCap":226729805296.57},{"date":"2025-08-01","current":27.450076,"twenty":31.285387,"median":38.59711,"eighty":65.682834,"marketCap":227698382305.18},{"date":"2025-08-08","current":27.389883,"twenty":31.239878,"median":38.507183,"eighty":65.361166,"marketCap":227199076245.22},{"date":"2025-08-15","current":29.344859,"twenty":31.148953,"median":38.320682,"eighty":64.905305,"marketCap":243415608857.5},{"date":"2025-08-22","current":30.340268,"twenty":31.053244,"median":38.195008,"eighty":64.339484,"marketCap":251672525941.34},{"date":"2025-08-29","current":29.776335,"twenty":30.79086,"median":38.076901,"eighty":64.10097,"marketCap":246994698975.95},{"date":"2025-09-05","current":30.363153,"twenty":30.666228,"median":38.015696,"eighty":63.603755,"marketCap":251862352359.71},{"date":"2025-09-12","current":29.927337,"twenty":30.393617,"median":37.932984,"eighty":63.299139,"marketCap":248247269052.01},{"date":"2025-09-19","current":28.645466,"twenty":30.311903,"median":37.873977,"eighty":62.462983,"marketCap":237614147208.25},{"date":"2025-09-26","current":27.449429,"twenty":30.181258,"median":37.760202,"eighty":61.578433,"marketCap":227693019996},{"date":"2025-10-03","current":31.722006,"twenty":30.157275,"median":37.691978,"eighty":61.182288,"marketCap":263134040754.4},{"date":"2025-10-10","current":31.779765,"twenty":30.157275,"median":37.646986,"eighty":60.857861,"marketCap":263613143515.1},{"date":"2025-10-17","current":31.527671,"twenty":30.157275,"median":37.61203,"eighty":59.786203,"marketCap":261522031415.6},{"date":"2025-10-24","current":31.210908,"twenty":30.157275,"median":37.512557,"eighty":58.437339,"marketCap":258894485628.07},{"date":"2025-10-31","current":30.645781,"twenty":30.157275,"median":37.385642,"eighty":57.126635,"marketCap":254206749846.85},{"date":"2025-11-07","current":27.892437,"twenty":30.05398,"median":37.224851,"eighty":56.544377,"marketCap":262161018116.77},{"date":"2025-11-14","current":29.465932,"twenty":29.907939,"median":37.187776,"eighty":55.975699,"marketCap":276950296874.71},{"date":"2025-11-21","current":29.849588,"twenty":29.82382,"median":37.124826,"eighty":55.19873,"marketCap":280556277388.82},{"date":"2025-11-28","current":30.557443,"twenty":29.82382,"median":37.050904,"eighty":54.957642,"marketCap":287209401693.86},{"date":"2025-12-05","current":29.941564,"twenty":29.800469,"median":36.962015,"eighty":54.235905,"marketCap":281420767708.56},{"date":"2025-12-12","current":29.764018,"twenty":29.784883,"median":36.821675,"eighty":53.767507,"marketCap":279752003848.48},{"date":"2025-12-19","current":30.21406,"twenty":29.784883,"median":36.62753,"eighty":53.285774,"marketCap":283981945416.43},{"date":"2025-12-26","current":30.509855,"twenty":29.784883,"median":36.3957,"eighty":53.285774,"marketCap":286762127698.97},{"date":"2026-01-02","current":30.214527,"twenty":29.784883,"median":36.24741,"eighty":53.285774,"marketCap":283986338067.91},{"date":"2026-01-09","current":31.507727,"twenty":29.784883,"median":36.112299,"eighty":53.017252,"marketCap":296141129485.56},{"date":"2026-01-16","current":31.047495,"twenty":29.784883,"median":35.820385,"eighty":52.672067,"marketCap":291815406526.34},{"date":"2026-01-23","current":30.236208,"twenty":29.777549,"median":35.710806,"eighty":52.385113,"marketCap":284190118048.85},{"date":"2026-01-30","current":30.915654,"twenty":29.777549,"median":35.485077,"eighty":51.606024,"marketCap":290576235840.63},{"date":"2026-02-06","current":31.509944,"twenty":29.777549,"median":35.416911,"eighty":50.936066,"marketCap":296161965984.29},{"date":"2026-02-13","current":31.237199,"twenty":29.777549,"median":35.301381,"eighty":50.526805,"marketCap":319400362950.55},{"date":"2026-02-20","current":31.148176,"twenty":29.777549,"median":35.234954,"eighty":50.526805,"marketCap":318490105234},{"date":"2026-02-27","current":31.852075,"twenty":29.777549,"median":35.181753,"eighty":50.526805,"marketCap":325687471757.28},{"date":"2026-03-06","current":29.253763,"twenty":29.772379,"median":35.070358,"eighty":50.526805,"marketCap":299119723159.18},{"date":"2026-03-13","current":29.124777,"twenty":29.706021,"median":34.983608,"eighty":50.526805,"marketCap":297800850037.39},{"date":"2026-03-20","current":28.184203,"twenty":29.505621,"median":34.905487,"eighty":50.526805,"marketCap":288183473946.5},{"date":"2026-03-27","current":28.940776,"twenty":29.421318,"median":34.860278,"eighty":50.526805,"marketCap":295919433140.34},{"date":"2026-04-02","current":30.757948,"twenty":29.407351,"median":34.837801,"eighty":50.526805,"marketCap":314500010126.83},{"date":"2026-04-10","current":31.009136,"twenty":29.407351,"median":34.765335,"eighty":50.526805,"marketCap":317068408971.87},{"date":"2026-04-17","current":31.023825,"twenty":29.407351,"median":34.651978,"eighty":50.526805,"marketCap":317218615353.71},{"date":"2026-04-24","current":28.590149,"twenty":29.391569,"median":34.490407,"eighty":50.526805,"marketCap":292334279990.28},{"date":"2026-05-01","current":27.393074,"twenty":29.330596,"median":34.363766,"eighty":50.526805,"marketCap":284586643248.23},{"date":"2026-05-08","current":27.118772,"twenty":29.247592,"median":34.251475,"eighty":50.526805,"marketCap":281736922047.37},{"date":"2026-05-15","current":27.436031,"twenty":29.137914,"median":34.201851,"eighty":50.526805,"marketCap":285032926583.35},{"date":"2026-05-22","current":27.847688,"twenty":29.028962,"median":34.170059,"eighty":50.526805,"marketCap":289309623974.59},{"date":"2026-05-29","current":27.687103,"twenty":28.948895,"median":34.144205,"eighty":50.565404,"marketCap":287641311510.04},{"date":"2026-06-05","current":27.793091,"twenty":28.854431,"median":34.094853,"eighty":50.526805,"marketCap":288742425885.62},{"date":"2026-06-12","current":26.813741,"twenty":28.664476,"median":33.99717,"eighty":50.526805,"marketCap":278567944858.78},{"date":"2026-06-18","current":25.993915,"twenty":28.599961,"median":33.930497,"eighty":50.526805,"marketCap":270050782509.13},{"date":"2026-06-26","current":28.247757,"twenty":28.539063,"median":33.890896,"eighty":50.565404,"marketCap":293465950818},{"date":"2026-07-02","current":29.0053,"twenty":28.516045,"median":33.859371,"eighty":50.565404,"marketCap":301336056942.59},{"date":"2026-07-10","current":25.670213,"twenty":28.45453,"median":33.745732,"eighty":50.565404,"marketCap":266687845425.44},{"date":"2026-07-17","current":25.347402,"twenty":28.27903,"median":33.675906,"eighty":50.565404,"marketCap":263334163881.47},{"date":"2026-07-24","current":25.171879,"twenty":28.221976,"median":33.645202,"eighty":50.565404,"marketCap":261510652126.53},{"date":"2026-07-31","current":25.213774,"twenty":28.125759,"median":33.580979,"eighty":50.604003,"marketCap":263383079752.11},{"date":"2026-08-07","current":23.762589,"twenty":28.068572,"median":33.528061,"eighty":50.604003,"marketCap":248224002580.32},{"date":"2026-08-14","current":22.966438,"twenty":28.014594,"median":33.447647,"eighty":50.604003,"marketCap":239907408698.88},{"date":"2026-08-21","current":24.485403,"twenty":27.993721,"median":33.394158,"eighty":50.604003,"marketCap":255774511601.32},{"date":"2026-08-28","current":24.15182,"twenty":27.957316,"median":33.310507,"eighty":50.604003,"marketCap":252289912448.87},{"date":"2026-09-04","current":24.131655,"twenty":27.898799,"median":33.260311,"eighty":50.604003,"marketCap":252079262054.64},{"date":"2026-09-11","current":23.517086,"twenty":27.849653,"median":33.190976,"eighty":50.604003,"marketCap":245659473869.4},{"date":"2026-09-14","current":24.326386,"twenty":27.847688,"median":33.179817,"eighty":50.604003,"marketCap":254113432295.37}],"updateTime":1789474584366},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667645276","title":"DESTINY-Lung04 III期臨床研究顯示，優赫得®一線治療HER2突變晚期非小細胞肺癌患者的中位無進展生存期達14.3個月","url":"https://stock-news.laohu8.com/highlight/detail?id=2667645276","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667645276?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:16","pubTimestamp":1789384560,"startTime":"0","endTime":"0","summary":"德曲妥珠单抗组的中位PFS为14.3个月，而帕博利珠单抗联合化疗组为8.3个月。\" 阿斯利康全球执行副总裁、肿瘤研发负责人Susan Galbraith表示：\"DESTINY-Lung04是首项在HER2突变晚期NSCLC患者中，证实PFS优于全球一线标准治疗的III期临床研究。在DESTINY-Lung04临床研究中，德曲妥珠单抗的安全性特征与其已知安全谱总体一致，未发现新的安全性问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5046853_ZH46853_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5046853_ZH46853_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["IE00B19Z4B17.USD","LU0128525929.USD","DCO","LU0432979614.USD","LU2237443465.HKD","LU0566484027.USD","BK4231","IE00B66KJ199.SGD","LU2237443978.SGD","LU2237443895.HKD","ADC","NETL","BK4007","BK4187","CR","ORR","LU2456880835.USD","FXN","PFS","LU2089984988.USD","PXI","LU2236285917.USD","LU2462157665.USD","LU1829250122.USD","LU0708994859.HKD","LU1267930573.SGD","LU2237443622.USD","ROKT","BK4585","AZNH","BK4568","LU0289739699.SGD","BK4213","LU0058720904.USD","LU0320765992.SGD","LU1559883803.SGD","LU0109394709.USD","LU2417539215.USD","LU0310800379.SGD","BK4588","IE0031619046.USD","IE00B7SZL793.SGD","PR","BK4161","AZN","LU2237443549.SGD","IE00B3T34201.USD","BK4195","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115044656","title":"異動解讀｜阿斯利康盤後下跌3.65%，報154.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1115044656","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115044656?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:33","pubTimestamp":1789158806,"startTime":"0","endTime":"0","summary":"9月12日，阿斯利康盘后下跌3.65%，报154.61美元/股，成交额244.99万美元。阿斯利康所在的制药行业中，个股中，礼来涨0.11%，默沙东跌0.02%，强生涨0.34%，辉瑞跌0.1%，诺和诺德持平。阿斯利康股份有限公司于1992年根据《公司法》在英格兰和威尔士注册成立，1999年与瑞典Astra公司合并。公司主营业务覆盖肿瘤、呼吸、罕见病等多个治疗领域，2007年收购美国生物制剂企业MedImmune，2021年收购罕见病企业Alexion。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666574841","title":"阿斯利康的乳腺癌藥物晚期臨床試驗失敗","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574841","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574841?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:29","pubTimestamp":1789158581,"startTime":"0","endTime":"0","summary":"阿斯利康的乳腺癌药物晚期临床试验失败路透9月11日-阿斯利康（AstraZeneca）AZN.L周五表示，其一款乳腺癌药物在晚期临床试验中未能达到改善无进展生存期的主要目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL4T4531G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443895.HKD","AZN","LU2456880835.USD","LU0889565916.HKD","LU0109394709.USD","BK4585","LU0058720904.USD","LU0320765992.SGD","LU1829250122.USD","LU2462157665.USD","LU2468319806.SGD","LU0310800379.SGD","LU2237443978.SGD","LU2237443465.HKD","LU0029864427.USD","BK4568","LU0289739699.SGD","BK4588","AZNH","LU0708994859.HKD","LU2237443382.USD","LU2417539215.USD","LU0432979614.USD","LU2237443549.SGD","BK4007","LU2236285917.USD","LU0128525929.USD","LU2237443622.USD","IE00B3T34201.USD","LU1267930573.SGD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666533439","title":"投洽會「金鑰匙」再啓：雙向投資動能強勁，未來產業站上C位","url":"https://stock-news.laohu8.com/highlight/detail?id=2666533439","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666533439?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 20:38","pubTimestamp":1788957480,"startTime":"0","endTime":"0","summary":"9月8日至11日，第二十六届中国国际投资贸易洽谈会(以下简称“投洽会”)在厦门国际博览中心举行。本届大会以“扩大双向投资共促全球发展”为永久主题，围绕“投资中国”“中国投资”“国际投 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260909/c679754294.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260909/c679754294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU2237443382.USD","LU0289739699.SGD","AZN","LU2236285917.USD","BK4588","LU2456880835.USD","LU2417539215.USD","AZNH","LU0029864427.USD","LU0058720904.USD","LU2237443622.USD","LU0310800379.SGD","LU1829250122.USD","LU2237443978.SGD","LU2468319806.SGD","LU0708994859.HKD","BK4007","LU0128525929.USD","LU0432979614.USD","LU0320765992.SGD","LU2237443895.HKD","BK4585","IE00B3T34201.USD","LU0889565916.HKD","LU2462157665.USD","LU2237443549.SGD","LU2089984988.USD","BK4568","LU2237443465.HKD","LU1267930573.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666712586","title":"安進（AMGN）聯合療法III期臨床達主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2666712586","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666712586?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 16:59","pubTimestamp":1788944360,"startTime":"0","endTime":"0","summary":"金吾财经 | 安进公布，双特异性T细胞衔接器Imdelltra联合阿斯利康PD-L1抑制剂英飞凡，在广泛期小细胞肺癌的后期临床试验中实现总生存期延长。这家加州生物制药企业披露III期DeLLphi-305研究中期数据，该试验达成广泛期小细胞肺癌患者总生存期主要终点。该项全球试验评估该组合作为一线维持治疗，受试者既往接受过包含英飞凡的治疗且病情未发生进展。研究同时达成无进展生存期、客观缓解率两项次要终点。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/NjNkZWQ4NGZiN2I3MDYxNDlhOTlmZGM4ZTUwODkzNDUzNTE2.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NjNkZWQ4NGZiN2I3MDYxNDlhOTlmZGM4ZTUwODkzNDUzNTE2.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305840","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","AMGN","BK4566","LU0109394709.USD","LU2468319806.SGD","LU2237443978.SGD","LU2112291526.USD","LU2237443895.HKD","BK4581","BIB","AZNH","PJP","LU0889565916.HKD","IE0002141913.USD","LU0128525929.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","LU2242652126.USD","BBH","IE00B4R5TH58.HKD","LU1571399168.USD","BK4533","LU1023059063.AUD","LU0058720904.USD","LU0868494617.USD","LU2456880835.USD","LU0708994859.HKD","IBBQ","LU2242646821.SGD","LU0289739699.SGD","LU0432979614.USD","LU1829250122.USD","IBB","LU2236285917.USD","IE00B2B36J28.USD","PBE","LU2237443622.USD","LU0029864427.USD","BK4139","BK4568","BK4534","BK4585","LU2237443382.USD","LU1267930573.SGD","LU2462157665.USD","LU2089984988.USD","TBXU","SG9999001440.SGD","AZN","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665968376","title":"Tozorakimab在OBERON和TITANIA兩項Ⅲ期臨床試驗中，在降低慢阻肺病急性加重方面均顯示出統計學和臨床意義上的顯著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2665968376","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665968376?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:18","pubTimestamp":1788873480,"startTime":"0","endTime":"0","summary":"OBERON和TITANIA两项Ⅲ期试验的结果令人鼓舞，证实tozorakimab在广泛患者人群中均能降低急性加重风险，有望帮助患者摆脱反复急性加重的困扰，获得全新的治疗选择。Tozorakimab 是首个在广泛慢阻肺病患者人群中显示出减少气道黏液栓堵塞作用的生物制剂3。Tozorakimab总体耐受性和安全性良好，唯一报告的药物不良反应为注射部位反应1,2。目前，tozorakimab已在欧盟、中国等主要市场进入上市许可审评阶段，用于治疗慢性阻塞性肺疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5042444_ZH42444_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5042444_ZH42444_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2237443382.USD","IBBQ","LU2237443895.HKD","LU2456880835.USD","BK4588","BK4568","LU2089984988.USD","LU2462157665.USD","LU0058720904.USD","AZN","BMED","LU2237443465.HKD","LU0708994859.HKD","IBBJ","BK4007","LU2468319806.SGD","LU0289739699.SGD","MDTX","LU0128525929.USD","LU0889565916.HKD","LU2236285917.USD","IE00B3T34201.USD","LU2237443549.SGD","LU0432979614.USD","LU1829250122.USD","AZNH","BK4585","LU2237443622.USD","LU0109394709.USD","LU0320765992.SGD","PSYK","LU1267930573.SGD","LU0310800379.SGD","LU2417539215.USD","LU0029864427.USD","LU2237443978.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665341019","title":"商務部新增84個全國重點外資項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2665341019","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665341019?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 12:05","pubTimestamp":1788840300,"startTime":"0","endTime":"0","summary":"【大河财立方记者程帅星厦门报道】9月8日，大河财立方记者在第二十六届中国国际投资贸易洽谈会(以下简称“投洽会”)上获悉，商务部近日新增84个全国重点外资项目，其中包括6个外资标志性项 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260908/c679692496.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260908/c679692496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU2756315318.SGD","LU2168563687.JPY","SKHZ","LU1989771016.USD","LU0158827781.USD","LU2328871848.SGD","LU2168564065.EUR","LU1093756325.SGD","LU2462591350.SGD","LU2471134523.USD","IE00BFTCPJ56.SGD","SG9999001176.USD","LU1023059063.AUD","IE00BWXC8680.SGD","LU2471134796.USD","LU0097036916.USD","CURE","LU0964807845.USD","SKHY","SKHN","BK0188","LU2089283258.USD","LU2360106947.USD","IE00B4JS1V06.HKD","LU2264538146.SGD","LU0823426480.USD","SGXZ31699556.SGD","LU0823397103.USD","LU1974910355.USD","LU1323610961.USD","LU0979878070.USD","LU2265009873.SGD","LU0058720904.USD","SG9999015986.USD","LU0516422366.SGD","BK1589","LU2361044949.HKD","LU1794554557.SGD","LU2236285917.USD","VHT","LU2461242641.AUD","LU0823413587.USD","LU2552382215.SGD","IE00B775H168.HKD","LU2750360997.AUD","IE00BJT1NW94.SGD","LU0061475181.USD","LU2111349929.HKD","BK0028","LU0823416689.USD","SGXZ99366536.SGD","IE00B1XK9C88.USD","LU0353189763.USD","LU0122379950.USD","LU1868837136.USD","LU2237443465.HKD","LU1280957306.USD","LU0689472784.USD","LU0096364046.USD","LU2491049909.HKD","LU0456855351.SGD","SKUU","LU0354030438.USD","IE0004445015.USD","LU2746668461.USD","LU0787776722.HKD","LU0466842654.USD","LU1629891620.HKD","LU2213496289.HKD","IE0001KFT4U8.USD","SG9999018857.SGD","SG9999014898.SGD","LU0327786744.USD","LU0823413660.USD","RXL","SG9999001176.SGD","LU0052750758.USD","SGXZ81514606.USD","AGNG","LU0516422440.USD","GDOC","LU2168564222.USD","LU0856984785.SGD","LU0114720955.EUR","LU2750360641.GBP","LU0708995401.HKD","LU0234572021.USD","LU0348825331.USD","LU1814569148.SGD","SG9999002463.SGD","LU1983299246.USD","SKHYV","IHE","LU0823434583.USD","LU2237438978.USD","LU2237443978.SGD","LU2271345857.HKD","LU1988902786.USD","LU0051755006.USD","LU0109394709.USD","LU2746668974.SGD","IE00BK4W5L77.USD","LU0326950275.SGD","MEDI","LU2357305700.SGD","LU0471298777.SGD","SG9999015978.USD","BK0208","LU0079474960.USD","LU3063872942.SGD","LU1691799644.USD","WDNA","LU2471134879.HKD","LU0029864427.USD","LU0203201768.USD","BK4568","HRTS","LU0128526141.USD","LU1969619763.USD","SKHA","LU2324357040.USD","IE00BJLML261.HKD","MHIP","LU0006306889.USD","LU1069344957.HKD","LU1880383366.USD","IE00B2B36J28.USD","LU1242518931.SGD","LU1720050803.USD","LU0819121731.USD","LU0348735423.USD","LU1868836757.USD","LU0882574139.USD","IYH","BK4533","BK4599","LU2063271972.USD","PPH","LU0029874061.USD","LU2089284900.SGD","LU1868837300.USD","SG9999017495.SGD","LU2211815571.USD","LU0174119429.USD","LU2361044865.SGD","LU1548497426.USD","ILDR","LU0359202008.SGD","LU0225283273.USD","LU2756315664.SGD","LU2468319806.SGD","LU2168564149.EUR","LU1551013425.SGD","LU2417539215.USD","IE00B4R5TH58.HKD","LU2462157665.USD","LU1688375341.USD","SG9999015952.SGD","LU0572944931.SGD","LU0640476718.USD","SGXZ57979304.SGD","SG9999018865.SGD","LU0203202063.USD","LU0256863811.USD","LU0516422952.EUR","LU0823426308.USD","LU1868836591.USD","LU0417516738.SGD","LU2552382058.USD","LU1035775433.USD","IE00B7KXQ091.USD","LU2106854487.HKD","BK0197","LU0198837287.USD","SG9999002562.SGD","LU0238689110.USD","LU2023250330.USD","LU2237443382.USD","LU1242518857.USD","LU1145028129.USD","TMED","IE00B1BXHZ80.USD","BK4581","LU0181495838.USD","MEDX","LLII","TRUH","LLYX","BK1521","LU0516423174.USD","LU1551013342.USD","IE00B3T34201.USD","LU2602419157.SGD","LU2108987350.USD","LU1291159041.SGD","LU2491050154.USD","LU0345770308.USD","LU0359201612.USD","LU1868836914.USD","LU1720051017.SGD","LU2028103732.USD","LU2552382132.HKD","LU0266013472.USD","LU2491050071.SGD","SG9999014880.SGD","LU2023251221.USD","LU2237443549.SGD","LU1979441026.SGD","LU2087625088.SGD","KURE","LU0289739699.SGD","LU0133085943.USD","LU2039709279.SGD","LU0943347566.SGD","LU1366192091.USD","LU0316494557.USD","LU1956131251.USD","LU0820561909.HKD","LU0210536198.USD","BK4585","IE0009355771.USD","LU1917777945.USD","IE0004445239.USD","BK4141","02269","IE0005OL40V9.USD","IE00BJJMRY28.SGD","BK1576","LU0823434740.USD","LU0385154629.USD","LU2168564495.EUR","LU0106261372.USD","LU1829250122.USD","IE00BKPKM429.USD","LU0417517546.SGD","PJP","IE00BJJMRX11.SGD","LU0889565916.HKD","LU2471134952.CNY","SG9999013999.USD","LU1232071149.USD","LU0310800379.SGD","SKHQ","BK1141","LU0471298694.HKD","LU0323591593.USD","IE00BJJMRZ35.SGD","THNR","LU0786609619.USD","SKHU","07709","SKHL","LLY","LU2896262040.SGD","LU0320765992.SGD","LU0158827948.USD","LU1127390331.HKD","IE0002141913.USD","LU0109391861.USD","BK4007","LU1057294990.SGD","LU0820561818.USD","AZNH","IE00BN29S564.USD","ELIL","LU2456880835.USD","OZEM","LU0039217434.USD","SKDD","FTXH","LU0672654240.SGD","WXXWY","LU0516423091.SGD","GB00BDT5M118.USD","BK4534","LU0456846285.SGD","LU0432979614.USD","LU1064131342.USD","LU0353189680.USD","LU2237443895.HKD","LU0708994859.HKD","LU0320765059.SGD","LU0820562030.AUD","LU2023250504.SGD","AZN","LU1267930573.SGD","JDOC","LU0354030511.USD","IE00BKDWB100.SGD","ABB","LU2237443622.USD","LU0588546209.SGD","LU0140636845.USD","HYNX","IE00BFSS7M15.SGD","LU0456827905.SGD","XLV","SG9999014914.USD","LU1093756168.USD","LU0094547139.USD","BK4096","SKHX","LU0683600562.USD","IXJ","LU1061106388.HKD","LU2089984988.USD","LU2361045086.USD","IE00BFSS8Q28.SGD","LU0708995583.HKD","BK0196","SGXZ51526630.SGD","LU1804176565.USD","LU1623119135.USD","LU0128525929.USD","LU0320764599.SGD","LU0307460666.USD","CANC","SK","SG9999014906.USD","BK4588","ELIS","BK4516","LU1712237335.SGD","SG9999015945.SGD","LU0823397285.USD","LU2112291526.USD","LU0417516902.SGD","LLYZ","BK1610","FHLC","LU1720051108.HKD","IE00BK4W5M84.HKD","BK0187","LU0256863902.USD","LU0345770993.USD","LU0882574055.USD","LU0043850808.USD","IE00B0JY6N72.USD","002493","LU1267930730.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665935968","title":"美國食品藥品監督管理局（FDA）加速批准阿斯利康(AZN.O)的Etcamah，用於治療伴有ESR1突變的晚期乳腺癌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665935968","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665935968?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 03:47","pubTimestamp":1788551256,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4007","LU0320765992.SGD","LU0128525929.USD","LU0289739699.SGD","LU2237443465.HKD","LU2468319806.SGD","LU0889565916.HKD","LABU","LU2237443382.USD","LU2236285917.USD","LU2237443895.HKD","LU1267930573.SGD","LU2237443549.SGD","LU0310800379.SGD","LU0058720904.USD","LU2462157665.USD","LU2089984988.USD","LU0432979614.USD","159151","LU2237443978.SGD","AZN","BK4568","IE00B3T34201.USD","BK4588","LU2456880835.USD","AZNH","BK4585","LU2417539215.USD","LU0109394709.USD","LU0708994859.HKD","LU2237443622.USD","LU1829250122.USD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664368853","title":"阿斯利康（AZN）抗體偶聯藥物Enhertu聯合療法獲歐盟新適應症批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2664368853","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664368853?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 18:36","pubTimestamp":1788258974,"startTime":"0","endTime":"0","summary":"金吾财讯 | 阿斯利康 与第一三共联合宣布，其抗体偶联药物Enhertu联合帕妥珠单抗的组合疗法已正式获得欧盟委员会批准，用于一线治疗不可切除或转移性HER2阳性乳腺癌成年患者。这也是Enhertu在短短两个月内于欧盟获得的第二个新适应症批准。随着这一欧盟监管决定的落地，阿斯利康将向第一三共支付1亿美元的里程碑付款。目前，该疗法已在包括美国、中国在内的全球40多个国家和地区获批上市。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/MWM3M2E1ZjMzOTEwODk1MDE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MWM3M2E1ZjMzOTEwODk1MDE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305553","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2236285917.USD","AZNH","LU2468319806.SGD","LU0058720904.USD","BK4568","BK4588","FSXEmain","IE00B3T34201.USD","LU0320765992.SGD","LU1829250122.USD","AZN","LU2237443978.SGD","LU2456880835.USD","LU1267930573.SGD","BK4585","LU2237443465.HKD","LU2237443895.HKD","LU0310800379.SGD","LU2237443549.SGD","LU2417539215.USD","LU0432979614.USD","LU0109394709.USD","LU0289739699.SGD","LU2089984988.USD","LU2237443382.USD","LU0128525929.USD","LU2462157665.USD","LU0029864427.USD","LU2237443622.USD","LU0708994859.HKD","FESXmain","BK4007","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167412971","title":"異動解讀｜阿斯利康夜盤下跌4.14%，多重管線挫折與競爭壓力持續承壓","url":"https://stock-news.laohu8.com/highlight/detail?id=1167412971","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167412971?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 15:02","pubTimestamp":1788246168,"startTime":"0","endTime":"0","summary":"9月1日，阿斯利康夜盘下跌4.14%，报155.42美元/股，成交额39.88万美元。近期阿斯利康面临多重负面因素叠加。竞争层面，Summit此前公布的依沃西单抗III期试验数据显示疗效优于阿斯利康核心肿瘤药Imfinzi，直接冲击其肿瘤免疫治疗市场地位。技术面上，阿斯利康股价近一个月已累计下跌逾5%，处于横盘偏弱格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"阿斯利康夜盘下挫，肿瘤管线屡遭挫折","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662671167","title":"療效碾壓阿斯利康(AZN.US)Imfinzi！Summit(SMMT.US)依沃西單抗III期試驗數據積極，股價應聲大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2662671167","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662671167?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 20:32","pubTimestamp":1787747523,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","LU0708994859.HKD","LU2237443978.SGD","BK4585","LU2237443382.USD","LU2468319806.SGD","LU1829250122.USD","III","LU2236285917.USD","LU0432979614.USD","LU2089984988.USD","LU2488822045.USD","LU0109394709.USD","LU1267930573.SGD","LU0128525929.USD","LU0029864427.USD","LU0289739699.SGD","BK4139","BK4134","LU2417539215.USD","LU0310800379.SGD","BK4568","BK4588","AZNH","LU0889565916.HKD","LU2237443465.HKD","SMMT","LU2456880835.USD","IE00B3T34201.USD","LU2237443895.HKD","LU2462157665.USD","LU2237443549.SGD","LU2237443622.USD","LU0320765992.SGD","AZN","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662976179","title":"國藥控股與阿斯利康啓動基藥惠民專項合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2662976179","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662976179?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 11:20","pubTimestamp":1787714411,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1267930573.SGD","BK4588","AZN","AZNH","LU2456880835.USD","LU2468319806.SGD","LU2237443549.SGD","LU2236285917.USD","BK4007","LU0289739699.SGD","LU2462157665.USD","LU0320765992.SGD","LU0128525929.USD","BK4568","LU2089984988.USD","LU2417539215.USD","LU0432979614.USD","LU0029864427.USD","LU2237443465.HKD","LU2237443622.USD","LU2237443895.HKD","IE00B3T34201.USD","LU0058720904.USD","LU0310800379.SGD","LU0889565916.HKD","LU2237443978.SGD","LU0708994859.HKD","LU2237443382.USD","BK4585","LU1829250122.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660917282","title":"迪哲醫藥上半年營收破5億，已與阿斯利康達成舒沃替尼全球獨家許可協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2660917282","media":"新浪财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660917282?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 20:55","pubTimestamp":1787230500,"startTime":"0","endTime":"0","summary":"8月20日，迪哲医药发布2026半年报，报告期内，公司实现营业收入5.23亿元，较上年同期增长47%。7月，迪哲医药与阿斯利康签署舒沃替尼的全球独家许可协议，授予阿斯利康在全球范围内独家开发、商业化舒沃替尼的权利。根据协议条款，迪哲医药将获得一次性、不可返还首付款6亿美元，最高达4亿美元的临床开发里程碑款项及最高达5亿美元的销售里程碑款项；此外，还将获得按舒沃替尼全球销售额阶梯式比例的特许权使用费。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-20/doc-ininynce7991209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AZN","09939","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660286748","title":"阿斯利康長效C5補體抑制劑偉立瑞獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2660286748","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660286748?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 18:58","pubTimestamp":1787223480,"startTime":"0","endTime":"0","summary":"南方财经8月20日电，记者获悉，阿斯利康罕见病业务旗下的长效C5补体抑制剂伟立瑞?（英文商品名：Ultomiris?，通用名：瑞利珠单抗注射液），已获得中国国家药品监督管理局（NMPA）批准，用于成人和1月龄及以上儿童阵发性睡眠性血红蛋白尿症（PNH）患者的治疗。PNH是一种慢性、进行性且危及生命的血液系统罕见疾病。该疾病好发于青壮年，77%的PNH患者在20-40岁发病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608203847950261.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608203847950261.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0128525929.USD","LU0432979614.USD","LU2237443465.HKD","LU2237443978.SGD","LU2237443895.HKD","BK4007","LU2456880835.USD","LU0889565916.HKD","LU2089984988.USD","IPOS","LU2236285917.USD","LU2462157665.USD","LU1829250122.USD","LU2468319806.SGD","LU0708994859.HKD","LU1267930573.SGD","LU2237443622.USD","BK4585","AZNH","BK4568","LU0289739699.SGD","LU2237443382.USD","LU0058720904.USD","LU0320765992.SGD","LU0109394709.USD","LU2417539215.USD","LU0310800379.SGD","BK4588","AZN","LU0029864427.USD","LU2237443549.SGD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660284301","title":"偉立瑞®在華獲批用於治療成人和1月齡及以上兒童陣發性睡眠性血紅蛋白尿症（PNH）患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2660284301","media":"美通社","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660284301?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 18:58","pubTimestamp":1787223480,"startTime":"0","endTime":"0","summary":"此次瑞利珠单抗获批，为成人及儿童PNH患者带来了兼具长效性、稳定性和便利性的治疗选择，可实现快速、完全且持续的终末补体抑制。目前，瑞利珠单抗在中国、美国、欧盟、日本等国家和地区获批用于治疗特定的阵发性睡眠性血红蛋白尿症的成人及儿童患者，并在全球多个国家和地区获批多项适应症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5030457_ZH30457_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5030457_ZH30457_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU0289739699.SGD","LU0310800379.SGD","LU0029864427.USD","LU2237443978.SGD","LU0889565916.HKD","LU2089984988.USD","LU0708994859.HKD","LU2456880835.USD","LU0432979614.USD","LU2468319806.SGD","LU2462157665.USD","LU2237443465.HKD","LU2237443622.USD","BK4007","LU1267930573.SGD","BK4568","BK4588","LU2237443895.HKD","IE00B3T34201.USD","AZN","BK4585","LU0058720904.USD","LU0109394709.USD","AZNH","LU0128525929.USD","LU0320765992.SGD","LU2237443549.SGD","LU2236285917.USD","LU2237443382.USD","LU2417539215.USD","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660407362","title":"阿斯利康(AZN.US)瑞利珠單抗第3項適應症在中國獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2660407362","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660407362?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 16:50","pubTimestamp":1787215836,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月20日，国家药品监督管理局官网显示，阿斯利康“瑞利珠单抗”国内再获批一项新适应症，用于治疗阵发性睡眠性血红蛋白尿症。瑞利珠单抗于2025年4月首次获批进入中国，用于治疗抗AChR抗体阳性的成人全身型重症肌无力，后又拓展适应症至NMOSD。瑞利珠单抗此次新适应症获批，成为国内第7款、进口第4款PNH治疗药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482601.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2237443465.HKD","LU1267930573.SGD","LU0128525929.USD","IE00B3T34201.USD","AZNH","LU2462157665.USD","LU2089984988.USD","LU0889565916.HKD","LU2417539215.USD","LU0289739699.SGD","LU2237443622.USD","LU2237443382.USD","LU2237443978.SGD","BK4585","AZN","LU1829250122.USD","LU0310800379.SGD","BK4007","IPOS","LU0320765992.SGD","LU0029864427.USD","BK4568","LU2237443895.HKD","LU0708994859.HKD","LU2237443549.SGD","LU2456880835.USD","LU0432979614.USD","LU2468319806.SGD","LU0058720904.USD","BK4588","LU0109394709.USD","LU2236285917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157086726","title":"異動解讀｜阿斯利康盤中上漲3.1%，多項肺癌III期研究積極結果疊加製藥板塊集體走強","url":"https://stock-news.laohu8.com/highlight/detail?id=1157086726","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157086726?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 22:22","pubTimestamp":1787149321,"startTime":"0","endTime":"0","summary":"8月19日，阿斯利康盘中上涨3.1%，报165.07美元，成交额1.27亿美元。消息面上，公司近日密集释放管线利好。8月17日，阿斯利康与第一三共联合宣布Enhertu单药一线治疗HER2突变非小细胞肺癌的III期DESTINY-Lung04研究取得积极结果，系全球首个在该适应症中单药击败标准疗法的ADC药物。同日，Tagrisso联合赛沃替尼的全球III期SAFFRON研究亦达到PFS和OS双重终点。此外，公司新药特泽利尤单抗已于8月17日宣布在中国正式上市，获批重度哮喘及慢性鼻窦炎伴鼻息肉两项适应症。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660450919","title":"阿斯利康(AZN.US)單抗新藥兩項適應症在中國上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2660450919","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660450919?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 15:41","pubTimestamp":1787038869,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月17日，阿斯利康宣布，特泽利尤单抗注射液在中国正式上市。2026年3月，特泽利尤单抗基于DIRECTION及WAYPOINT两项3期临床研究的阳性结果，在中国获批两项适应症：用于成人和12岁及以上青少年重度哮喘的维持治疗；本品与鼻用糖皮质激素联合使用，治疗系统性糖皮质激素和/或手术治疗无法充分控制疾病的慢性鼻窦炎伴鼻息肉成人患者。特泽利尤单抗是由阿斯利康与安进合作开发的人源单克隆抗体，可抑制TSLP的活性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481297.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2089984988.USD","LU2237443895.HKD","LU1267930573.SGD","AZN","LU0128525929.USD","LU0432979614.USD","LU0109394709.USD","LU2237443978.SGD","IE00B3T34201.USD","LU2237443382.USD","LU2456880835.USD","LU2237443622.USD","IPOS","LU2417539215.USD","LU1829250122.USD","LU0708994859.HKD","BK4585","LU0289739699.SGD","BK4007","LU2468319806.SGD","LU2462157665.USD","LU0320765992.SGD","LU2237443465.HKD","AZNH","BK4568","LU0889565916.HKD","LU2237443549.SGD","LU2236285917.USD","BK4588","LU0058720904.USD","LU0310800379.SGD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660498480","title":"第3次更新-阿斯利康因暫停volrustomig肺癌臨床試驗再遭挫折","url":"https://stock-news.laohu8.com/highlight/detail?id=2660498480","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660498480?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 20:57","pubTimestamp":1786971447,"startTime":"0","endTime":"0","summary":"阿斯利康此前曾预测，volrustomig的峰值销售额将超过50亿美元。该公司表示，volrustomig与化疗联合使用时的安全性特征与各药物已知的安全性特征一致，未发现新的安全性信号。Volrustomig是一种双重检查点抑制剂双特异性抗体，旨在解除PD-1和CTLA-4这两条关键免疫通路的抑制，从而帮助免疫系统攻击肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4T44E0V2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029864427.USD","BK4585","LU0708994859.HKD","BK4568","LU2236285917.USD","LU0289739699.SGD","LU1267930573.SGD","LU2237443382.USD","LU0320765992.SGD","LU2237443622.USD","LU1829250122.USD","LU2237443895.HKD","IE00B3T34201.USD","LU2456880835.USD","LU0058720904.USD","LU0128525929.USD","LU2237443978.SGD","LU2417539215.USD","LU2237443465.HKD","AZN","LU0109394709.USD","LU0310800379.SGD","LU2089984988.USD","AZNH","BK4588","BK4007","LU0432979614.USD","LU2237443549.SGD","LU2468319806.SGD","LU0889565916.HKD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660248062","title":"阿斯利康(AZN.US)/第一三共ADC一線治療肺癌III期研究成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2660248062","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660248062?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 20:44","pubTimestamp":1786970699,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月17日，阿斯利康和第一三共联合宣布Enhertu单药一线治疗非小细胞肺癌的III期DESTINY-Lung04研究取得了高水平的积极结果。结果显示，Enhertu组患者的PFS较标准治疗组实现了统计学显著且临床意义显著的改善。值得一提的是，Enhertu是第一个在III期研究中成功证明单药相较标准治疗作为一线治疗方案能够改善NSCLC患者的PFS的ADC药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480994.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2456880835.USD","LU2237443465.HKD","AZN","LU2237443622.USD","LU0029864427.USD","LU2237443382.USD","LU0058720904.USD","LU0889565916.HKD","LU2468319806.SGD","NETL","LU1829250122.USD","BK4568","LU2237443978.SGD","BK4007","BK4585","LU2237443895.HKD","LU2462157665.USD","LU2237443549.SGD","LU2236285917.USD","BK4588","III","LU2089984988.USD","LU0708994859.HKD","LU0432979614.USD","LU0109394709.USD","BK4080","LU1267930573.SGD","LU0320765992.SGD","ADC","BK4134","LU2417539215.USD","LU0289739699.SGD","BK4231","LU0128525929.USD","AZNH","IE00B3T34201.USD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}